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The risk of developing normal tissue injuries often limits the radiation dose that can be applied to the
tumour in radiation therapy. Microbeam Radiation Therapy (MRT), a spatially fractionated photon
radiotherapy is currently tested at the European Synchrotron Radiation Facility (ESRF) to improve normal
tissue protection. MRT utilizes an array of microscopically thin and nearly parallel X-ray beams that are
generated by a synchrotron. At the ion microprobe SNAKE in Munich focused proton microbeams
(“proton microchannels”) are studied to improve normal tissue protection. Here, we comparatively
investigate microbeam/microchannel irradiations with sub-millimetre X-ray versus proton beams to
minimize the risk of normal tissue damage in a human skin model, in vitro. Skin tissues were irradiated
with a mean dose of 2 Gy over the irradiated area either with parallel synchrotron-generated X-ray
beams at the ESRF or with 20 MeV protons at SNAKE using four different irradiation modes: homoge-
neous ﬁeld, parallel lines and microchannel applications using two different channel sizes. Normal tissue
viability as determined in an MTT test was signiﬁcantly higher after proton or X-ray microchannel
irradiation compared to a homogeneous ﬁeld irradiation. In line with these ﬁndings genetic damage, as
determined by the measurement of micronuclei in keratinocytes, was signiﬁcantly reduced after proton
or X-ray microchannel compared to a homogeneous ﬁeld irradiation. Our data show that skin irradiation
using either X-ray or proton microchannels maintain a higher cell viability and DNA integrity compared
to a homogeneous irradiation, and thus might improve normal tissue protection after radiation therapy.
© 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In radiotherapy, the risk of developing normal tissue injuries
often limits the radiation dose that can be applied in tumour pa-
tients. Radiation damage in the skin can reduce the patient's quality
of life after tumour therapy. Microbeam Radiation Therapy (MRT), a
spatially fractionated radiotherapy, uses an array of microscopically
thin and nearly parallel synchrotron-generated X-ray beams [1e3].
In X-ray MRT the tumour is exposed to arrays of narrow 25e75 mm
wide microplanar beams. These parallel orientated beams areica. Published by Elsevier Ltd. Thisseparated by distances of typically 50e400 mm. The microarray
geometry is maintained in the tumour, and comparisons between
broad beam irradiations and MRT indicate a higher therapeutic
index due to less toxicity in the normal tissue and a selective
radiovulnerability of the tumour vasculature versus normal blood
vessels by MRT [4e6].
Similar approaches use focused proton microbeams, here
termed “microchannels”, which remain separated in normal tissues
but spread out until they reach the tumour to achieve a homoge-
neous dose distribution inside the target volume. The rationale for
proton microchannels is therefore the reduction of normal tissue
toxicity (as in X-ray MRT), while the response of the target volume
is unaffected. The microchannel approach has been established at
the ion microprobe SNAKE in Munich [7]. A microchannelis an open access article under the CC BY-NC-ND license (http://creativecommons.
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ﬂammatory response in a human skin model compared to con-
ventional homogeneous broad-beam irradiation [7]. They applied
protons either focused in a matrix of 500  500 mm2 (total ﬁeld
size: 4  4 mm2) using 50  50 mm2 wide channels with a channel
dose of 200 Gy, or homogeneously with the same mean dose of
2 Gy. Inﬂammation was determined by measuring soluble inﬂam-
matory response parameters such as Interleukin-6, TGF-beta and
Pro-MMP1 in the supernatant of the human skin tissue. The results
showed a lower inﬂammatory response in the human skin model
after microchannel compared to homogeneous irradiation. No
signiﬁcant cell death was observed in the skin after irradiationwith
50 mm microchannels compared to non-irradiated controls, while
homogeneously irradiated tissues showed a decrease in the cell
viability of 48%.
In 2013, another group published Monte Carlo simulations for
microchannel proton irradiations [8]. The authors evaluated peak-
to-valley doses for several arrays of proton minibeams and
concluded possible tissue sparing effects due to the spatial frac-
tionation of the dose.
The major goal of the present study was to investigate if micro-
channel irradiation (using a similar concept as “pencilbeam” or
“minibeam” irradiations, cf. [9] and [8]) in themicrometre size range
of X-ray versus proton beams can also minimize the risk of normal
tissue damage. Therefore, viability and genetic damage was deter-
mined in a three-dimensional human skinmodel after four different
microbeam irradiationmodes: a homogeneous ﬁeld (HF), lines (LN),
and small and large channels (SC and LC) with synchrotron-
generated X-ray beams at the ESRF (Grenoble, France) and proton
irradiation at the SNAKE microbeam (Munich, Germany).
Materials and methods
Tissue construct
The three-dimensional full-thickness skin model EpiDermFT™,
which was used in previous studies [7], was obtained from MatTek
Corporation, Ashland, MA, USA. For the irradiations at SNAKE the
EFT-400 with a surface area of 1 cm2 (thickness roughly half a
millimetre) and for the irradiations at the ESRF the EFT-300 was
used, which is the same as EFT-400 except the surface areawas only
0.9 cm2. This reconstructed human skin is a differentiated tissue
consisting of corniﬁed, granular, spinous and basal layer like the
normal human epidermis, and a dermal layer. EpiDermFT™ is
mitotically and metabolically active. The tissue, consisting of
human-derived epidermal keratinocytes and dermal ﬁbroblasts, is
cultured on special cell culture inserts in 12-well plates, each
containing 2.0 ml of fresh 37 C NewMaintenance Medium (NMM,
MatTek Corporation, Ashland, MA, USA). The samples were incu-
bated at 37 C in a humidiﬁed atmosphere (5% CO2), replacing the
culture medium every 24 h.
Irradiation conditions at SNAKE (protons)
Proton irradiationwas carried out at the Munich ionmicroprobe
SNAKE (Superconducting Nanoprobe for Applied nuclear [Kern]
physics Experiments) of the 14 MV Munich tandem accelerator,
where deﬁned cell nuclei can be irradiated with single or counted
protons, thus allowing a precise dose application [10e12]. During
irradiation, the skin construct was retained in a specially designed
container (cf. [7,12]) and mounted directly behind the beam exit
nozzle, with the dermis facing the beam. For an exact dose calcu-
lation, every proton was detected in a scintillator-photomultiplier
detector after traversing the skin sample [7], with an LET value of
2.66 keV/mm at the position of the skin sample. The sameirradiation setup was used to prepare the beam for two focused
modes (channel modes) and for a homogeneous mode. In all three
cases the average dose over the irradiated area was 2 Gy, with an
uncertainty of approximately 4%, estimated mainly from the un-
certainty of the ﬁeld size (~2% in each dimension) and the accuracy
of the LET value (~1e2%) [13,7]. For the microchannel irradiations,
the channel size and distance was chosen such that 1% of the skin
was irradiated. Small channels (SC, 50  50 mm2, as in Ref. [7]) and
large channels (LC,180 180 mm2) were irradiatedwith a local dose
of 200 Gy and the distances between the channels were 500 mm
(centre-to-centre) and 1800 mm, respectively. Three skin samples
were used for each irradiation mode, and the whole experiment
was performed in duplicate.
Irradiation conditions at ESRF (X-rays)
A very similar irradiationwas performed with X-rays at the ID17
beamline of the European Synchrotron Radiation Facility (ESRF) in
Grenoble/France, which is also used for theMRTactivities at ESRF. It
is equipped with a multi-slit tungsten collimator and a goniometer
which can move the sample through the beam in order to generate
microplanar beams as used inMRT [3]. The energy spectrum ranges
from 50 to 350 keV with the maximum at around 100 keV. A
specially designed tissue holder allowed the skin sample to be
mounted on the goniometer, with the dermis facing the source. The
skin sample was sandwiched between 2 mm of PMMA towards the
source (to provide sufﬁcient build-up) and 9 mm water (medium)
followed by 6 mm of PMMA on the other side. A circular tungsten
mask with 4.6 mm diameter was mounted immediately upstream
of the sample.
For this setup, four irradiation modes were prepared: a homo-
geneous ﬁeld (HF), lines (LN), and small and large channels (SC and
LC). The vertical lines had a thickness of 51 mm and a distance
(centre-to-centre) of 412 mm (deﬁned by the multi-slit collimator),
with the samplemoving through the beam as for MRT. By using one
horizontal line of 51 mmwidth with the same multi-slit collimator
settings, a linear array of small channels of 51  51 mm2 with a
distance (centre-to-centre) of 412 mm could be generated. Vertical
stepping of the samplewith a step size (centre-to-centre) of 607 mm
produced the desired SC pattern with one channel per 0.25 mm2,
very similar to the SC pattern realized at SNAKE. A large channel
(LC) with 180  180 mm2 was generated by primary slits (without
the multi-slit collimator, and without the 4.6 mm collimator), and
the sample was moved horizontally and vertically in steps of
1800 mm (centre-to-centre) in order to realize the same pattern as
for large channels at SNAKE. Three skin samples were used for each
irradiation mode.
In all four irradiation modes, the intended average dose over the
irradiated area was 2 Gy. The required peak doses and output fac-
tors for irradiation (relative to a pin point ionization chamber
measurement in an open ﬁeld of 10 10mm2) were determined by
detailed Monte Carlo simulations in Geant4 version 9.3p2 on a
lateral calculation gridwith a resolution of 5 mm. The Livermore low
energy physics libraries were employed with 1 mm cut of lengths.
These simulations were used to determine the mean dose over the
nominal ﬁeld size and to scale this dose to 2 Gy for all irradiation
modes. Due to the shallower beam penumbra compared to protons,
the resulting peak doses were lower than for protons (e.g. 186 Gy
for SC and 15.1 Gy for LN compared to 200 Gy at SNAKE), with valley
doses for X-rays of around 0.03 Gy.
MTT tissue viability test
The cell viability of the complete skin (i.e. keratinocytes in the
epidermis and ﬁbroblasts in the dermis) was quantiﬁed 40 h after
S. Girst et al. / Physica Medica 31 (2015) 615e620 617irradiation using the colorimetric MTT test (MTT-100, MatTek
Corporation). The MTT substrate is only cleaved by active mito-
chondria and the amount of formazan generated in this enzymatic
reaction correlates closely to the cell number [14]. It is assumed
that the cleavage of the MTT substrate by active mitochondria is
strongly correlatedwith the number of viable cells within 40 h after
irradiation. In brief, the central part (diameter 4 mm) of the irra-
diated area was punched out using a centred mask and placed in
300 ml MTT solution for 3 h at 37 C, followed by overnight
extraction at room temperature in 2 ml extraction solution. After
removal of the tissues, 200 ml of the sample was measured with a
photospectrometer to obtain the optical density (OD) at 570 nm,
subtracting background at 650 nm. The percentage viability was
calculated for each tissue, dividing the corrected OD by the OD of
untreated controls [7].
Micronuclei test
Genetic damage in epidermal keratinocytes was measured via
the micronuclei assay as described earlier [12,7]. Immediately after
irradiation, 3 mg/ml cytochalasin B was added into the culture
medium and the cultures were incubated for a further 48 h at 37 C
in a humidiﬁed atmosphere of 5% CO2 in air. The 48 h incubation
was considered to be the optimal timewhere up to 50% binucleated
cells were reproducibly obtained. After cutting the central part
(diameter 4 mm at ESRF, 5 mm at SNAKE) of the tissue by a biopsy
punch, keratinocytes were isolated as described by Zlobinskaya
et al. [7]. The number of micronuclei (MN) was only counted in
binucleated cytokinesis-block (CB) cells containing detached MN in
the cytoplasm in order to measure the frequency of MN only in the
ﬁrst division after irradiation. At least 500 binucleated CB cells with
well-preserved cytoplasm were analysed for each sample of the
proton and X-ray irradiations and from sham irradiated controls.
Dermal ﬁbroblasts were not scored because of their low density
and long cell cycle duration.
Results
Dose distributions
Dose distributions for the proton microchannel irradiations at
SNAKE were quantiﬁed using Gafchromic EBT2 ﬁlms (International
Speciality Products, USA), using a dedicated calibration curve
[15,16] and by scaling the number of particles to ﬁt the dynamic
dose range of the ﬁlms (i.e. increased total ﬂuence to measure
valley doses). The analysed irradiation pattern revealed that at least
93% of the area contained less than 1% of the applied mean dose in
the two focused modes (SC and LC), indicating a valley dose of less
than 0.02 Gy for 93% of the irradiated area (for details see Ref. [7]).
The spatial dose distributions for X-rays at ESRF were also veriﬁed
by EBT2 ﬁlms, which were calibrated in the ESRF beam against an
ion chamber. Again, exposure times were scaled in order to capture
the valley doses in the dynamic range of the ﬁlm. Figure 1 shows
representative examples for homogeneous ﬁeld (HF), lines (LN),
small channel (SC) and large channel (LC) irradiation modes.
MTT tissue viability test
Cell viability of the EpiDermFT™ tissue was measured 40 h after
irradiation following the MTT-100 protocol developed at MatTek
Corporation by using the enzymatic, colorimetric MTT assay on the
central part (diameter 4 mm) of the tissue. Pooled mean values of
three independent experiments and the standard error are shown
in Table 1 and Fig. 2. The larger uncertainty bars of the X-ray
experiment are due to higher variation in the control samples,which are used for normalization of all other samples. To determine
a statistical signiﬁcance between the different application modes,
an un-paired t-test was applied on the non-normalized data. Cell
viability after homogeneous irradiation with protons was
39.8 ± 2.1% and 38.9 ± 6.1% for X-rays if compared to non-irradiated
controls. After microchannel irradiation with small channels
(50  50 mm2, SC), the cell viability was signiﬁcantly higher
(p < 0.05; normalized values: 79.4 ± 0.5% for protons and
79.2 ± 13.6% for X-rays) if the same mean dose was used. Micro-
channel irradiation of large channels (180  180 mm2, LC) and
irradiation in 50 mm lines showed also signiﬁcantly higher cell
viability (p < 0.05) than after homogeneous irradiation for both
protons and X-ray. However, the viability data of the two different
microchannel irradiations (LC and SC) and the 50 mm lines (LN) did
not show any signiﬁcant differences. Furthermore, there was no
signiﬁcant difference between protons and X-rays for any of the
irradiation modes.
Micronuclei assay
Genetic damage as determined by the measurement of micro-
nuclei in keratinocytes was also signiﬁcantly reduced after micro-
channel irradiation compared to homogeneous irradiation. Table 2
and Fig. 3 represent the results induced by protons and X-ray
irradiation, which have been determined with the different irra-
diation modes (n ¼ 3). To test for statistical signiﬁcances, an un-
paired t-test was carried out for the yields of micronuclei.
For the homogeneous irradiation mode (HF), the number of
micronuclei per cytokinesis-blocked (CB) binucleated cell was
0.070 ± 0.005 for protons and 0.067 ± 0.009 for X-rays. Micro-
channel irradiation with small (SC) and large (LC) channels, as well
as after irradiation in 50 mm lines (LN), signiﬁcantly (p < 0.05)
reduced the number of MN per CB cell at the same mean dose for
protons as well as X-rays. The values for small channels (SC) were
0.030 ± 0.005 for protons and 0.031 ± 0.006 for X-rays, the values
for large channels (LC) were 0.015 ± 0.003 and 0.027 ± 0.006,
respectively. X-ray line irradiation (LN) induced 0.023 ± 0.005 MN
per CB cell. No signiﬁcant differences were found in the number of
MN per CB cell between the two microchannel modes (SC, LC) and
the 50 mm lines (LN). As for the MTT test, no signiﬁcant difference
between protons and X-rays was seen for any of the irradiation
modes.
Discussion and conclusions
The risk of developing normal tissue injuries limits the radiation
dose that can be applied to the target volume in radiotherapy.
During the last decades the treatment techniques have evolved, and
inmodern radiotherapy damage to normal tissues can be limited by
using highly conformal treatment planning techniques for photon
and proton beams. However, even with most advanced radio-
therapy techniques, many patients develop skin reactions at the
irradiated area [17]. The severity of acute skin reactions is corre-
lated to the delivered total dose, the dose per fraction and to the
size of the treatment area. Acute radiation effects in the skin usually
manifest initially as a slight erythema and can progress later from
dry desquamation to conﬂuentmoist desquamation [17]. Therefore,
patients often feel discomfort, which can range from a mild irrita-
tion to considerable pain. Since several decades it is known that
acute radiation damage to skin involves both, the epidermis and
dermis [18]. The basal layer of the epidermis proliferates very fast
and is particularly sensitive to radiotherapy. Within 14 days after
irradiation, the epidermis shows necrosis and inter-cellular
oedema as a result of cell death of post-mitotic keratinocytes in
the upper viable layers of the epidermis. Therefore, the
Figure 1. Dose distributions of four irradiation modes at ESRF: homogeneous ﬁeld (HF), lines (LN), small channels (SC) and large channels (LC), measured with radiochromic ﬁlm.
Scale bars: 2 mm.
Table 1
MTT test results at SNAKE and ESRF.
SNAKE ESRF
CO 100.0 ± 0.5 100.0 ± 14.3
HF 39.8 ± 2.1 38.9 ± 6.1
LN Not tested 77.9 ± 15.5
SC 79.4 ± 0.5 79.2 ± 13.6
LC 82.5 ± 1.2 81.4 ± 12.9
Figure 2. MTT test results at SNAKE and ESRF. Cell viability of homogeneous ﬁeld (HF),
line (LN), small channel (SC) and large channel (LC) irradiation was measured at the
central part (diameter 4 mm) of the irradiated area after 40 h by the MTT assay. Un-
certainty bars represent the SD of the mean value of three independently irradiated
tissue samples, where negative control (CO) is sham treated.
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takes another 2e4 weeks to heal after the end of radiotherapy.
The aim of our study was to investigate if microchannel irradi-
ations with micrometre sized X-ray or proton beams can minimize
the risk of normal tissue damage in the skin (independently of the
biological response at the depth of the tumour, which might be
quite different between X-ray MRT and proton microchannel irra-
diation due to the different scattering properties). It is well estab-
lished that normal tissues can tolerate high doses of radiation over
small volumes. Therefore, the “valley” dose in the gaps between
adjacentmicrobeams has to be kept as low as possible to achieve an
optimal normal tissue sparing effect. A previous study indicated
that skin is highly resistant to X-ray microbeam irradiations [19].
The authors showed that even high doses up to 925 Gy (90 mm
beams with 300 mm spacing, valley dose about 2.5%) were well
tolerated in a rat skin model. No moist desquamation has been
observed. The recovery of the damaged segments after microbeam
irradiation of the skin was attributed to surviving cells, localizedbetween the irradiated areas with clonogenic potential that pro-
liferate and lead to fast re-epithelialization [19]. Another study
demonstrated that a peak entrance dose of 200 Gy with MRT
produced similar histological responses in the skin to a broad beam
irradiation with 11 Gy [20]. However, this study also showed that
Table 2
Micronuclei test results at SNAKE and ESRF.
SNAKE ESRF
CO 0.011 ± 0.004 0.012 ± 0.003
HF 0.070 ± 0.005 0.067 ± 0.009
LN Not tested 0.023 ± 0.005
SC 0.030 ± 0.005 0.031 ± 0.006
LC 0.015 ± 0.003 0.027 ± 0.006
Figure 3. Micronuclei assay at SNAKE and ESRF. Mean number of micronuclei per
divided, cytokinesis-block (CB) cell for control (CO), homogeneous ﬁeld (HF), line (LN),
small channel (SC) and large channel (LC) irradiations measured after 48 h. Uncertainty
bars represent the SD of the mean value of three independently irradiated tissue
samples.
S. Girst et al. / Physica Medica 31 (2015) 615e620 619apoptosis in epithelial cells was not conﬁned to the path of the
microbeams through the tissue. This might be attributed to high
valley doses (2e16 Gy) which induces the migratory capacity of
epidermal cells out of the irradiated area later.
Our investigations were performed in a human skin tissue
model in order to account for the 3D geometry and the commu-
nication between different cell types such as keratinocytes and ﬁ-
broblasts. This model has been proven to be valid for assessing the
induction of micronuclei after proton and X-ray radiation
[7,12,21,22].
Our comparative study proved the potential of proton as well as
X-ray microchannel radiotherapy to spare normal tissue from acute
and long-term side effects by spatial fractionation. Both, cell
viability and genetic damage measured at SNAKE and ESRF showed
the same superiority of microchannel irradiation compared to
conventional homogeneous broad beam irradiation, for protons as
well as for X-rays. This applies to all investigated micro-irradiation
modes (lines, small and large channels). It is important to note that
cell viability and genetic damage results were not signiﬁcantly
different after proton and X-ray irradiations in all irradiation
modes. This indicates that rather the mode of radiation application
than the radiation quality does impact cell viability.
It is also important to note that due to the higher survival rate of
cancer patients in recent years, the risk to develop radiation
induced second tumours has now become of greater importance
than ever [23]. It was recently shown that the frequency of
micronuclei can be predictive of the cancer risk, which suggests
that higher amounts of genetic damage after irradiation is corre-
lated with early events in carcinogenesis [24]. In our study, the
lower number of micronuclei in skin keratinocytes after micro-
channel irradiation may imply a reduced risk to develop mutations
in normal tissues, because there is a close relationship between
chromosome aberrations and gene mutations and cancerpredisposition after irradiation exposure [25]. Therefore the lower
number of micronuclei in skin keratinocytes after microchannel
irradiation may lead to a reduced risk to develop second tumours.
In conclusion, our study indicates that microchannel irradia-
tions with either micrometre sized X-ray as well as proton beams
can minimize the risk of skin damage in an in vitro human skin
model. Future animal models are required to assess long-term ef-
fects of microchannel irradiation on normal tissues, in vivo.Conﬂicts of interest
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